Drug and protein delivery by polymer conjugation

作者: Antonella Grigoletto , Katia Maso , Anna Mero , Antonio Rosato , Oddone Schiavon

DOI: 10.1016/J.JDDST.2015.08.006

关键词: PEG ratioPEGylationDrug deliveryHomogeneousMaterials scienceHigh activityDrugNanotechnologyNew chemical entityPolymer

摘要: Abstract Drug and protein delivery techniques methods, which, in most cases, are concurrently investigated from the very time a new molecular entity is proposed, have become valuable tools for development of numerous therapeutic molecules. Attracting attention academia industrial researchers, several polymer conjugation methodologies been shown to wide range applications success rate that confirmed by conjugates already clinical use or under investigation on-going trials. Having attained high level sophistication, this technology able generate homogeneous exploiting specifically designed coupling strategies (based, example, on enzymes), which ensure good product characterization, activity retention, batch-to-batch reproducibility. Poly(ethylene glycol) (PEG), current gold standard stealth polymers emerging field polymer-based drug delivery, competition with other convenient features such as biodegradability. PEG still holds first place far PEGylated derivatives trials concerned, it will presumably remain choice even future further improvements copolymers based overcome example hurdle

参考文章(117)
Merry R. Sherman, L. David Williams, Monika A. Sobczyk, Shawnya J. Michaels, Mark G. P. Saifer, Role of the Methoxy Group in Immune Responses to mPEG-Protein Conjugates Bioconjugate Chemistry. ,vol. 23, pp. 485- 499 ,(2012) , 10.1021/BC200551B
E.A. Balaz, T.C. Laurent, New applications for hyaluronan Wenner-Gren Symposium. ,vol. 72, pp. 325- ,(1998)
A Abuchowski, T van Es, N C Palczuk, F F Davis, Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. Journal of Biological Chemistry. ,vol. 252, pp. 3578- 3581 ,(1977) , 10.1016/S0021-9258(17)40291-2
Nicole C.C. Them, Klaudia Bagienski, Tiina Berg, Bettina Gisslinger, Martin Schalling, Doris Chen, Veronika Buxhofer‐Ausch, Josef Thaler, Ernst Schloegl, Guenther A. Gastl, Dominik Wolf, Karin Strecker, Alexander Egle, Thomas Melchardt, Sonja Burgstaller, Ella Willenbacher, Oleh Zagrijtschuk, Christoph Klade, Richard Greil, Heinz Gisslinger, Robert Kralovics, Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2b. American Journal of Hematology. ,vol. 90, pp. 288- 294 ,(2015) , 10.1002/AJH.23928
A Abuchowski, J R McCoy, N C Palczuk, T van Es, F F Davis, Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. Journal of Biological Chemistry. ,vol. 252, pp. 3582- 3586 ,(1977) , 10.1016/S0021-9258(17)40292-4
Michael Hofmann, Valliant, Managing dialysis patients who develop anemia caused by chronic kidney disease: focus on peginesatide. International Journal of Nanomedicine. ,vol. 8, pp. 3297- 3307 ,(2013) , 10.2147/IJN.S44944
Razelle Kurzrock, Sanjay Goel, Jennifer Wheler, David Hong, Siqing Fu, Keyvan Rezai, Sonia K. Morgan-Linnell, Saik Urien, Sridhar Mani, Imran Chaudhary, Mohammed H. Ghalib, Aby Buchbinder, François Lokiec, Mary Mulcahy, Safety, pharmacokinetics, and activity of EZN-2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignancies. Cancer. ,vol. 118, pp. 6144- 6151 ,(2012) , 10.1002/CNCR.27647
Nancy J Ganson, Susan J Kelly, Edna Scarlett, John S Sundy, Michael S Hershfield, Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase. Arthritis Research & Therapy. ,vol. 8, pp. 1- 10 ,(2005) , 10.1186/AR1861
Olaf Kinstler, Graham Molineux, Michael Treuheit, David Ladd, Colin Gegg, Mono-N-terminal poly(ethylene glycol)-protein conjugates. Advanced Drug Delivery Reviews. ,vol. 54, pp. 477- 485 ,(2002) , 10.1016/S0169-409X(02)00023-6